# ACCESS2 Stakeholder Walkthrough Feedback And Go/No-Go Note

## Purpose

This note records the first stakeholder walkthrough feedback checkpoint for the current ACCESS2 demo package. It is a documentation record only. It does not approve production mutation, staging mutation, Railway mutation, new runtime behavior, or architecture changes.

## Walkthrough Record

- Walkthrough date: May 18, 2026.
- Walkthrough version: v1.
- Audience/stakeholder type: initial stakeholder walkthrough; specific stakeholder role was not separately recorded.
- Supporting screen prints: `ACCESS2_walkthrough_1.gdoc`.

## What Was Demonstrated

- The ACCESS2 stakeholder walkthrough v1 script was executed.
- The walkthrough used the current demo package and printable walkthrough guide.
- The demonstrated story remained within the current release posture:
  - V1 production is a read-only demo.
  - V2 correction-loop mutation remains localhost-only.
  - Staging mutation remains deferred until isolated staging or preview infrastructure is explicitly approved.

## What Landed Well

- The walkthrough completed and everything looked good.
- No specific UI, copy, workflow, or proof-chain issues were reported.

## What Caused Confusion

- No concrete confusion was reported.
- Context note: this was net-new for the audience, and no one had a prior expectation for what the UI should look like.

## Objections Or Risks Raised

- No objections were reported.
- No new risks were raised.

## Follow-Up Questions

- No follow-up questions were recorded.

## Go/No-Go Recommendation

Recommendation: go for continued stakeholder walkthrough use of the current ACCESS2 demo package in its existing safety posture.

This is not a blanket product approval and does not authorize production mutation, staging mutation, Railway mutation, or broader V2 expansion. It only indicates that the v1 walkthrough package is acceptable to keep using for additional stakeholder review unless future feedback identifies a concrete blocker.

## Recommended Next ACCESS2 Slice

Recommended next slice: run another stakeholder walkthrough using the same package and capture structured feedback, especially around:

- Whether the chronic-care outcome accountability story is clear.
- Whether the immutable review packet and audit bundle explanation is clear.
- Whether the V1 read-only versus V2 localhost-only boundary is clear.
- Whether any stakeholder asks for staging, workflow mutation, EHR/FHIR, billing, AI, or admin capabilities.

If the next walkthrough remains clear, keep the current package stable. If specific confusion appears, use a small docs/copy clarity slice rather than changing product behavior.

## Safety Confirmation

- Production remained read-only.
- V2 mutation remained localhost-only.
- No production mutation testing was requested or run.
- No staging mutation testing was requested or run.
- No Railway mutation was requested or run.
- No real PHI, secrets, EHR/FHIR integration, billing integration, AI features, broad UI redesign, admin features, or override approval work was introduced.
- Immutable review packet snapshot assumptions remain preserved.
